Development of an individual display optimization system based on deep convolutional neural network transition learning for somatostatin receptor scintigraphy-Reference-Cited by-同舟云学术

Development of an individual display optimization system based on deep convolutional neural network transition learning for somatostatin receptor scintigraphy

Published:2024-01-02 Issue:1 Volume:17 Page:195-206
ISSN:1865-0333
Container-title:Radiological Physics and Technology
language:en
Short-container-title:Radiol Phys Technol

Author:

Matsumoto Shun^ORCID,Nakahara Yuki,Yonezawa Teppei,Nakamura Yuto,Tanabe Masahiro,Higashi Mayumi,Shiraishi Junji

Funder

PDRadiopharma Inc.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12194-023-00766-7.pdf

Reference19 articles.

1. Tsuchikawa T, Takeuchi S, Hirata K. Current treatment trends and perspectives in neuroendocrine tumors (NET). Ther Res. 2022;43(11):901–10 ((in Japanese)).

2. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063–72. https://doi.org/10.1200/JCO.2007.15.4377.

3. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59. https://doi.org/10.1002/10.1002/cncr.11105.

4. Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42. https://doi.org/10.1001/jamaoncol.2017.0589.

5. Masui T, Ito T, Komoto I, et al. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer. 2020;20(1):1104. https://doi.org/10.1186/s12885-020-07581-y.